Management of metastatic castration-resistant prostate cancer: Insights from urology experts in Thailand

Management of metastatic castration-resistant prostate cancer: Insights from urology experts in Thailand

Treatment options for castration-resistant prostate cancer (CRPC) are available, but clear instructions for the selection of appropriate treatment are lacking. A meeting of urology experts based in Thailand was convened with the following objectives: (1) to reach a consensus and share real-life expe...

Full description

Bibliographic Details
Main Authors: Bannakij Lojanapiwat, Choosak Pripatnanont, Vorapot Choonhaklai, Surithorn Soontornpun, Supon Sriplakich, Sunai Leewansangtong, Apirak Santi-ngamkun, Julin Opanuraks, Wisoot Kongcharoensombat, Bhapapak Na-Songkla, Wiroj Raksakul, Chagkrapan Predanon
Format: Article
Language:English
Published: Elsevier 2017-03-01
Series:Prostate International
Subjects:
Abiraterone acetate
Androgen receptor
Metastatic castration-resistant prostate cancer
Prostate-specific antigen
Urology expert
Online Access:http://www.sciencedirect.com/science/article/pii/S2287888216300794

Internet

http://www.sciencedirect.com/science/article/pii/S2287888216300794

Similar Items